Determine the Dosing Interval and Optimal Dose of AYP-101 for the Reduction of Submental Fat in Chin Area

Inclusion Criteria: * Male and female over 19 and under 65 years old * Localized submental fat under chin area and who meet all the following criteria. ① Determined as grade 2 (moderate) or 3 (severe) on both using the CR-SMFRS and PR-SMFRS at visit 1 ② Determined as grade 2 (less satisfied) or less by oneself, using the SSRS at visit 1 * Stable weight over the last 6 months (body weight change within +/-10%), subject who should refrain from exercise and diet that may affect the study results, and who agreed to remain it for the study period * Singed informed consent Exclusion Criteria: * Allergic to beans, components of the clinical drug, or medical devices which used in this clinical trial (lidocaine, acetaminophen, sterile oil pan, alcohol swab, grid pad, needle, etc.) * Central, endocrine, or hereditary obesity (BMI 35kg/m2 or more) * History of any treatment (orthognathic surgery, suction lipectomy, PPC or DCA injection) in the neck or chin area * History of any treatment such as mesotherapy, carboxy, laser surgery, acupuncture needle, filler, chemical peeling with in 1 year, and a botox surgery within 6 months before screening * Judged to be unsuitable subject for the clinical trials; ① Abnormal or sagging skin, ② Noticeable platysma band under the chin area, ③ Less or short chin than normal ④ Chin or neck disease that are considered to have an impact on the clinical trial such as lymphadenopathy, Inflammation, scars, or surgery on the injection area * History …